DEA Revokes Ohio Doctor's Controlled Substances Registration
Published Date: 4/2/2025
Notice
Summary
Jennifer Marie Lager-Fermon, D.O., lost her Ohio medical license in January 2024 and didn’t ask for a hearing to fight it. Because of that, the DEA is officially revoking her registration to handle controlled substances, meaning she can no longer prescribe or manage these drugs. This decision is final and affects her ability to work with controlled substances immediately.
Analyzed Economic Effects
1 provisions identified: 0 benefits, 1 costs, 0 mixed.
DEA Registration Revoked for Ohio Physician
The DEA revoked Jennifer Marie Lager-Fermon, D.O.'s Certificate of Registration No. BL7988960, effective May 2, 2025, because her Ohio medical license was indefinitely suspended effective January 16, 2024. As a result, she may no longer prescribe, dispense, or otherwise handle controlled substances and any pending DEA registration applications for her in Ohio are denied.
Personalized for You
How does this regulation affect your finances?
Personalize government policy and PRIA will tell you what this federal register document means for your household, plus every other regulation we track. PRIA reads each provision against your financial profile to show you exactly what matters to your wallet.
Key Dates
Department and Agencies
Related Federal Register Documents
2026-11526, Implementation of the Substance Use-Disorder Prevention That Promotes Opioid Recovery and Treatment for Patients and Communities Act of 2018: Dispensing and Administering Controlled Substances for Medication-Assisted Treatment
Starting July 9, 2026, new rules make it easier for doctors and pharmacies to provide medicine that helps people recover from opioid addiction. These changes affect healthcare providers by expanding who can give medication-assisted treatment and how pharmacies can deliver these medicines. The goal? Faster, safer access to treatment with clear rules that save time and support recovery.
2026-10128, Revision of Applications for Manufacturing and Procurement Quotas
The DEA wants to update how companies apply for permission to make and buy certain controlled drugs and chemicals. These changes will make the rules clearer, help prevent drug shortages, and ensure enough supply for medical and scientific needs. If you’re a manufacturer or involved in this process, get ready to follow new steps and share your thoughts by July 20, 2026.
2025-05007, Expansion of Buprenorphine Treatment via Telemedicine Encounter and Continuity of Care via Telemedicine for Veterans Affairs Patients
Starting December 31, 2025, veterans can get buprenorphine treatment and follow-up care through telemedicine, making it easier to access help for opioid use disorder without leaving home. This change affects veterans using VA health services and aims to improve treatment access while the government reviews feedback and policies. No new costs are mentioned, but the delay gives agencies time to ensure the rules work well.
2025-02793, Expansion of Buprenorphine Treatment via Telemedicine Encounter and Continuity of Care via Telemedicine for Veterans Affairs Patients
The government is giving veterans easier access to buprenorphine treatment through telemedicine, letting them get care remotely. This change affects veterans using VA health services and aims to make treatment smoother and more convenient. The new rules were supposed to start February 18, 2025, but now they’ll kick in on March 21, 2025, while the government gathers public feedback.
2026-20227, St. Michael's Pharmacy; Decision and Order
St. Michael's Pharmacy in Texas had its DEA license suspended and is facing revocation because it kept filling risky drug prescriptions without fixing obvious warning signs of abuse. This affects the pharmacy’s ability to legally handle controlled substances and could impact patients relying on it. The pharmacy must now deal with these serious legal actions, which started in late 2025 and could lead to permanent closure or fines.
2026-20226, By Grace Inc. Counseling Services; Decision and Order
By Grace Inc. Counseling Services in Baltimore faced losing its DEA license because it didn’t keep good records and lied about its owner’s past drug conviction. After a hearing, the DEA decided to revoke their registration, meaning they can’t legally handle controlled substances anymore. This affects the clinic’s ability to operate and could impact patients relying on their services.
Previous / Next Documents
Previous: 2025-05663, Amendment of Notice of Funding Availability for Multifamily Housing Programs
The USDA’s Rural Housing Service is updating its 2024 funding programs for multifamily housing by removing references to the previous Administration’s priorities and diversity scoring rules. This change follows a new Executive Order and means applicants won’t be judged on those old criteria. If you already applied, don’t worry—you don’t need to apply again, and the update takes effect April 2, 2025.
Next: 2025-05665, New Postal Products
The Postal Service has asked for approval of a new deal that changes how some mail services work. This affects businesses and customers using competitive postal products, with a chance to share thoughts by April 4, 2025. The changes could mean new options or tweaks to existing services, but no immediate price changes are mentioned.